Attached files
| file | filename |
|---|---|
| 8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | d667958d8k.htm |
| EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | d667958dex992.htm |
| EX-99.3 - EX-99.3 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | d667958dex993.htm |
Exhibit 99.1
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Consolidated Balance Sheets
(Unaudited)
| December 31, | ||||||||
| (in thousands, except per share amounts) | 2013 | 2012 | ||||||
| Assets |
||||||||
| Current assets |
||||||||
| Cash and cash equivalents |
$ | 26,362 | $ | 46,540 | ||||
| Investments |
86,166 | 54,040 | ||||||
| Accounts receivable |
2,746 | 2,822 | ||||||
| Inventory, net |
10,050 | 9,592 | ||||||
| Prepaid expenses and other current assets |
1,135 | 2,006 | ||||||
|
|
|
|
|
|||||
| Total current assets |
126,459 | 115,000 | ||||||
| Property and equipment, net |
9,236 | 14,329 | ||||||
| Other long-term assets |
490 | 354 | ||||||
|
|
|
|
|
|||||
| Total assets |
$ | 136,185 | $ | 129,683 | ||||
|
|
|
|
|
|||||
| Liabilities and Stockholders’ Equity |
||||||||
| Current liabilities |
||||||||
| Accounts payable |
$ | 1,717 | $ | 2,988 | ||||
| Accrued expenses and other current liabilities |
9,797 | 8,204 | ||||||
| Deferred service revenue, current |
4,046 | 3,378 | ||||||
| Deferred development revenue, current |
6,785 | — | ||||||
| Facility financing obligation, current |
210 | 173 | ||||||
|
|
|
|
|
|||||
| Total current liabilities |
22,555 | 14,743 | ||||||
| Deferred service revenue, non-current |
518 | 800 | ||||||
| Deferred development revenue, non-current |
26,519 | — | ||||||
| Deferred rent and other long-term liabilities |
1,114 | 2,145 | ||||||
| Notes payable, non-current |
13,347 | — | ||||||
| Financing derivative |
549 | — | ||||||
| Facility financing obligation, non-current |
2,403 | 2,613 | ||||||
|
|
|
|
|
|||||
| Total liabilities |
67,005 | 20,301 | ||||||
|
|
|
|
|
|||||
| Stockholders’ equity |
||||||||
| Convertible Preferred Stock, $0.001 par value: |
||||||||
| Authorized 50,000 shares; No shares issued or outstanding at December 31, 2013 and 2012 |
— | — | ||||||
| Common Stock and additional paid-in-capital, $0.001 par value: |
||||||||
| Authorized 1,000,000 shares; Issued and outstanding 66,275 and 56,170 shares at December 31, 2013 and 2012, respectively |
684,479 | 645,372 | ||||||
| Accumulated other comprehensive income |
14 | 30 | ||||||
| Accumulated deficit |
(615,313 | ) | (536,020 | ) | ||||
|
|
|
|
|
|||||
| Total stockholders’ equity |
69,180 | 109,382 | ||||||
|
|
|
|
|
|||||
| Total liabilities and stockholders’ equity |
$ | 136,185 | $ | 129,683 | ||||
|
|
|
|
|
|||||